Kristen Gleason

Dr. Kristen Gleason


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2018 in Health Care for Women International
Verified
Journal Article
Closed access
SMStephanie McManimen
Stephanie McManimen
DMDamani McClellan
Damani McClellan
JSJamie Stoothoff
Jamie Stoothoff
KGKristen Gleason
Kristen Gleason
LJLeonard Jason
Leonard Jason
In the US, medical training is inadequate regarding the symptomatology, prognosis, and treatment for myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS). As a result, many physicians lack the appropriate level of knowledge about effective methods for ME and CFS symptom reduction and often suggest inappropriate treatments, such as increased exercise or psychiatric services. The authors’ purpose in this study was to analyze negative patient experiences with health care professionals. Patients with ME and CFS who reported experiencing a dismissive physician attitude were asked to detail the encounter via open-ended response on an international, online survey. Participant responses were thematically coded and analyzed using processes outlined by Patton. Emergent themes related to perceived physician attitudes and how they impact patient wellbeing are described and their implications discussed. Additionally, we highlight suggestions for how the health care system can effectively approach this often marginalized patient group.

12 October 2017 in Fatigue: Biomedicine, Health & Behavior
Verified
Journal Article
Closed access
LJLeonard Jason
Leonard Jason
PFPamela A. Fox
Pamela A. Fox
KGKristen Gleason
Kristen Gleason
All scientific activities with diseases rely on the selection of reliable and valid case definitions in order to accurately estimate prevalence rates, to identify biological markers, and to understand the outcomes of treatment trials. The failure to develop a consensus on which research case definition to use for defining Myalgic Encephalomyelitis (ME) and chronic fatigue syndrome (CFS) has had negative consequences for the scientific and patient community. If case definition criteria inappropriately select patients with symptoms due to primary affective disorders, other fatiguing medical conditions, burnout, or over-committed lifestyle issues, the scientific consequences are serious. For example, a case definition that is too broad would include individuals with other illnesses and conditions, complicating the tasks of estimating prevalence rates or identifying effective treatment programs. A consensus on a research case definition and its operationalization and assessment would enable investigators to select more homogenous samples that could expedite the identification of valid biological markers, and consequently reduce misperceptions regarding the role of psychogenic versus biomedical factors. Our editorial reviews the implications of previous research and clinical case definitions in CFS and ME domains.

5 June 2018 in International Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
KGKristen Gleason
Kristen Gleason
JSJamie Stoothoff
Jamie Stoothoff
DMDamani McClellan
Damani McClellan
SMStephanie McManimen
Stephanie McManimen
TTTaylor Thorpe
Taylor Thorpe
LJLeonard Jason
Leonard Jason

18 December 2017 in Journal of Community Psychology
Verified
Journal Article
Closed access
PDF file
KGKristen Gleason
Kristen Gleason
CBCharlene K. Baker
Charlene K. Baker
AMAshley Maynard
Ashley Maynard

13 March 2017 in American Journal of Community Psychology
Verified
Journal Article
Closed access
PDF file
KGKristen Gleason
Kristen Gleason
JBJohn P. Barile
John P. Barile
CBCharlene K. Baker
Charlene K. Baker

2 July 2016 in Fatigue: Biomedicine, Health & Behavior
Verified
Journal Article
Closed access
TTTaylor Thorpe
Taylor Thorpe
SMStephanie McManimen
Stephanie McManimen
KGKristen Gleason
Kristen Gleason
JSJamie Stoothoff
Jamie Stoothoff
JNJulia L. Newton
Julia L. Newton
LJLeonard Jason
Leonard Jason
Background: Myalgic encephalomyelitis and chronic fatigue syndrome have case definitions with varying criteria, but almost all criteria require an individual to have a substantial reduction in activity level. Unfortunately, a consensus has not been reached regarding what constitutes substantial reductions. One measure that has been used to measure substantial reduction is the Medical Outcomes Study Short-Form-36 Health Survey (SF-36). [ 1 Ware JE , Sherbourne CD . The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473–483. doi: https://doi.org/10.1097/00005650-199206000-00002 [Crossref], [PubMed], [Web of Science ®] , [Google Scholar] ] Purpose: The current study examined the relationship between the SF-36, a measure of current functioning, and a self-report measure of the percent reduction in hours spent on activities. Results: Findings indicated that select subscales of the SF-36 accurately measure significant reductions in functioning. Further, this measure significantly differentiates patients from controls. Conclusion: Determining what constitutes a significant reduction in activity is difficult because it is subjective to the individual. However, certain subscales of the SF-36 could provide a uniform way to accurately measure and define substantial reductions in functioning.